Epidemiology and transmission of kaposi’s sarcoma-associated herpesvirus

Viruses

Volumn 6, Issue 11, 2014, Pages 4178-4194

  Minhas, Veenu ^a,b   Wood, Charles ^a  

^a UNIVERSITY OF NEBRASKA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Epidemiology; HHV 8; KSHV; Transmission

Indexed keywords

PHORBOL ESTER; VIRUS DNA;

BLOOD TRANSFUSION; BREAST MILK; DISEASE MODEL; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GEOGRAPHY; HEALTH BEHAVIOR; HEALTH CARE POLICY; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; INFECTION RISK; KAPOSI SARCOMA; NONHUMAN; PREGNANCY; REVIEW; SALIVA; SCHISTOSOMIASIS; SEROPREVALENCE; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS TRANSMISSION; VOLCANIC ASH; ZAMBIA; HEALTH; HERPESVIRIDAE INFECTIONS; ISOLATION AND PURIFICATION; PREVALENCE; RISK FACTOR; TOPOGRAPHY; TRANSMISSION; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

ENDEMIC DISEASES; GLOBAL HEALTH; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; PREVALENCE; RISK FACTORS; TOPOGRAPHY, MEDICAL;

EID: 84908693478     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v6114178     Document Type: Review

References (87)

1. Cesarman, E.; Chang, Y.; Moore, P.S.; Said, J.W.; Knowles, D.M. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in aids-related body-cavity-based lymphomas. N. Engl. J. Med. 1995, 332, 1186–1191.
2. Chang, Y.; Cesarman, E.; Pessin, M.S.; Lee, F.; Culpepper, J.; Knowles, D.M.; Moore, P.S. Identification of herpesvirus-like DNA sequences in aids-associated kaposi’s sarcoma. Science 1994, 266, 1865–1869.
3. Schulz, T.F. Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8). J. Gen. Virol. 1998, 79, 1573–1591.
4. Soulier, J.; Grollet, L.; Oksenhendler, E.; Cacoub, P.; Cazals-Hatem, D.; Babinet, P.; d’Agay, M.F.; Clauvel, J.P.; Raphael, M.; Degos, L. et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric castleman’s disease. Blood 1995, 86, 1276–1280.
5. Sunil, M.; Reid, E.; Lechowicz, M.J. Update on hhv-8-associated malignancies. Curr. Infect. Dis. Rep. 2010, 12, 147–154.
6. Ziegler, J.L.; Bragg, K.; Abrams, D.; Beckstead, J.; Cogan, M.; Volberding, P.; Baer, D.; Wilkinson, L.; Rosenbaum, E.; Grant, K. et al. High-grade non-hodgkin’s lymphoma in patients with aids. Ann. N. Y. Acad. Sci. 1984, 437, 412–419.
7. Cook-Mozaffari, P.; Newton, R.; Beral, V.; Burkitt, D.P. The geographical distribution of kaposi’s sarcoma and of lymphomas in africa before the aids epidemic. Br. J. Cancer 1998, 78, 1521–1528.
8. Blauvelt, A.; Sei, S.; Cook, P.M.; Schulz, T.F.; Jeang, K.T. Human herpesvirus 8 infection occurs following adolescence in the united states. J. Infect. Dis. 1997, 176, 771–774.
9. Dedicoat, M.; Newton, R. Review of the distribution of kaposi’s sarcoma-associated herpesvirus (kshv) in africa in relation to the incidence of kaposi’s sarcoma. Br. J. Cancer 2003, 88, 1–3.
10. Gao, S.J.; Kingsley, L.; Li, M.; Zheng, W.; Parravicini, C.; Ziegler, J.; Newton, R.; Rinaldo, C.R.; Saah, A.; Phair, J. et al. Kshv antibodies among americans, italians and ugandans with and without kaposi’s sarcoma. Nat. Med. 1996, 2, 925–928.
11. Martro, E.; Bulterys, M.; Stewart, J.A.; Spira, T.J.; Cannon, M.J.; Thacher, T.D.; Bruns, R.; Pellett, P.E.; Dollard, S.C. Comparison of human herpesvirus 8 and epstein-barr virus seropositivity among children in areas endemic and non-endemic for kaposi’s sarcoma. J. Med. Virol. 2004, 72, 126–131.
12. Pellett, P.E.; Wright, D.J.; Engels, E.A.; Ablashi, D.V.; Dollard, S.C.; Forghani, B.; Glynn, S.A.; Goedert, J.J.; Jenkins, F.J.; Lee, T.H. et al. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among us blood donors. Transfusion 2003, 43, 1260–1268.
13. Weiss, R.A.; Whitby, D.; Talbot, S.; Kellam, P.; Boshoff, C. Human herpesvirus type 8 and kaposi’s sarcoma. J. Natl. Cancer Inst. Monogr. 1998, 23, 51–54.
14. Stolka, K.; Ndom, P.; Hemingway-Foday, J.; Iriondo-Perez, J.; Miley, W.; Labo, N.; Stella, J.; Abassora, M.; Woelk, G.; Ryder, R. et al. Risk factors for kaposi’s sarcoma among hiv-positive individuals in a case control study in cameroon. Cancer Epidemiol. 2014, 38, 137–143.
15. Biggar, R.J.; Whitby, D.; Marshall, V.; Linhares, A.C.; Black, F. Human herpesvirus 8 in brazilian amerindians: A hyperendemic population with a new subtype. J. Infect. Dis. 2000, 181, 1562–1568.
16. de Souza, V.A.; Sumita, L.M.; Nascimento, M.C.; Oliveira, J.; Mascheretti, M.; Quiroga, M.; Freire, W.S.; Tateno, A.; Boulos, M.; Mayaud, P. et al. Human Herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian amazon region. J. Infect. Dis. 2007, 196, 844–852.
17. De Sanjose, S.; Mbisa, G.; Perez-Alvarez, S.; Benavente, Y.; Sukvirach, S.; Hieu, N.T.; Shin, H.R.; Anh, P.T.; Thomas, J.; Lazcano, E. et al. Geographic variation in the prevalence of kaposi sarcoma-associated herpesvirus and risk factors for transmission. J. Infect. Dis. 2009, 199, 1449–1456.
18. Fu, B.; Sun, F.; Li, B.; Yang, L.; Zeng, Y.; Sun, X.; Xu, F.; Rayner, S.; Guadalupe, M.; Gao, S.J. et al. Seroprevalence of kaposi’s sarcoma-associated herpesvirus and risk factors in xinjiang, china. J. Med. Virol. 2009, 81, 1422–1431.
19. Mei, Q.; Ming, Z.W.; Ping, Y.X.; Hui, J.J.; Bin, Z.Y.; Hong, W.; Juan, L.; Zhe, C.Y.; Wei, T.; Han, Y. Hhv-8 seroprevalence in blood donors and hiv-positive individuals in shandong area, china. J. Infect. 2007, 55, 89–90.
20. Wang, H.; Liu, J.; Dilimulati Li, L.; Ren, Z.; Wen, H.; Wang, X. Seroprevalence and risk factors of kaposi’s sarcoma-associated herpesvirus infection among the general uygur population from south and north region of xinjiang, china. Virol. J. 2011, 8, 539.
21. Cao, Y.; Minhas, V.; Tan, X.; Huang, J.; Wang, B.; Zhu, M.; Gao, Y.; Zhao, T.; Yang, L.; Wood, C. High prevalence of early childhood infection by kaposi’s sarcoma-associated herpesvirus in a minority population in china. Clin. Microbiol. Infect. 2014, 20, 475–481.
22. Bayley, A.C. Occurrence, clinical behaviour and management of kaposi’s sarcoma in zambia. Cancer Surv. 1991, 10, 53–71.
23. Patil, P.; Elem, B.; Zumla, A. Pattern of adult malignancies in zambia (1980–1989) in light of the human immunodeficiency virus type 1 epidemic. J. Trop. Med. Hyg. 1995, 98, 281–284.
24. Patil, P.S.; Elem, B.; Gwavava, N.J.; Urban, M.I. The pattern of paediatric malignancy in zambia (1980–1989): A hospital-based histopathological study. J. Trop. Med. Hyg. 1992, 95, 124–127.
25. Chintu, C.; Athale, U.H.; Patil, P.S. Childhood cancers in zambia before and after the hiv epidemic. Arch. Dis. Child 1995, 73, 100–104.
26. Chen, T.; Hudnall, S.D. Anatomical mapping of human herpesvirus reservoirs of infection. Mod. Pathol. 2006, 19, 726–737.
27. Kedes, D.H.; Operskalski, E.; Busch, M.; Kohn, R.; Flood, J.; Ganem, D. The seroepidemiology of human herpesvirus 8 (kaposi’s sarcoma-associated herpesvirus): Distribution of infection in ks risk groups and evidence for sexual transmission. Nat. Med. 1996, 2, 918–924.
28. Mantina, H.; Kankasa, C.; Klaskala, W.; Brayfield, B.; Campbell, J.; Du, Q.; Bhat, G.; Kasolo, F.; Mitchell, C.; Wood, C. Vertical transmission of kaposi’s sarcoma-associated herpesvirus. Int. J. Cancer 2001, 94, 749–752.
29. Mbulaiteye, S.M.; Pfeiffer, R.M.; Whitby, D.; Brubaker, G.R.; Shao, J.; Biggar, R.J. Human herpesvirus 8 infection within families in rural tanzania. J. Infect. Dis. 2003, 187, 1780–1785.
30. Cannon, M.J.; Dollard, S.C.; Smith, D.K.; Klein, R.S.; Schuman, P.; Rich, J.D.; Vlahov, D.; Pellett, P.E. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N. Engl. J. Med. 2001, 344, 637–643.
31. Martin, J.N.; Ganem, D.E.; Osmond, D.H.; Page-Shafer, K.A.; Macrae, D.; Kedes, D.H. Sexual transmission and the natural history of human herpesvirus 8 infection. N. Engl. J. Med. 1998, 338, 948–954.
32. Melbye, M.; Cook, P.M.; Hjalgrim, H.; Begtrup, K.; Simpson, G.R.; Biggar, R.J.; Ebbesen, P.; Schulz, T.F. Risk factors for kaposi’s-sarcoma-associated herpesvirus (kshv/hhv-8) seropositivity in a cohort of homosexual men, 1981–1996. Int. J. Cancer 1998, 77, 543–548.
33. Dukers, N.H.; Renwick, N.; Prins, M.; Geskus, R.B.; Schulz, T.F.; Weverling, G.J.; Coutinho, R.A.; Goudsmit, J. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am. J. Epidemiol. 2000, 151, 213–224.
34. Smith, N.A.; Sabin, C.A.; Gopal, R.; Bourboulia, D.; Labbet, W.; Boshoff, C.; Barlow, D.; Band, B.; Peters, B.S.; de Ruiter, A. et al. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J. Infect. Dis. 1999, 180, 600–606.
35. Eltom, M.A.; Mbulaiteye, S.M.; Dada, A.J.; Whitby, D.; Biggar, R.J. Transmission of human herpesvirus 8 by sexual activity among adults in lagos, nigeria. AIDS 2002, 16, 2473–2478.
36. Lavreys, L.; Chohan, B.; Ashley, R.; Richardson, B.A.; Corey, L.; Mandaliya, K.; Ndinya-Achola, J.O.; Kreiss, J.K. Human herpesvirus 8: Seroprevalence and correlates in prostitutes in mombasa, kenya. J. Infect. Dis. 2003, 187, 359–363.
37. Baeten, J.M.; Chohan, B.H.; Lavreys, L.; Rakwar, J.P.; Ashley, R.; Richardson, B.A.; Mandaliya, K.; Bwayo, J.J.; Kreiss, J.K. Correlates of human herpesvirus 8 seropositivity among heterosexual men in kenya. AIDS 2002, 16, 2073–2078.
38. Butler, L.M.; Dorsey, G.; Hladik, W.; Rosenthal, P.J.; Brander, C.; Neilands, T.B.; Mbisa, G.; Whitby, D.; Kiepiela, P.; Mosam, A. et al. Kaposi sarcoma-associated herpesvirus (kshv) seroprevalence in population-based samples of african children: Evidence for at least 2 patterns of kshv transmission. J. Infect. Dis. 2009, 200, 430–438.
39. Malope, B.I.; MacPhail, P.; Mbisa, G.; MacPhail, C.; Stein, L.; Ratshikhopha, E.M.; Ndhlovu, L.; Sitas, F.; Whitby, D. No evidence of sexual transmission of kaposi’s sarcoma herpes virus in a heterosexual south african population. Aids 2008, 22, 519–526.
40. Zhang, T.; Yang, Y.; Yu, F.; Zhao, Y.; Lin, F.; Minhas, V.; Wood, C.; He, N. Kaposi`s sarcoma associated herpesvirus infection among female sex workers and general population women in shanghai, china: A cross-sectional study. BMC Infect. Dis. 2014, 14, 58.
41. Zavitsanou, A.; Sypsa, V.; Petrodaskalaki, M.; Psichogiou, M.; Katsoulidou, A.; Boletis, J.; Hadjiconstantinou, V.; Karalis, D.; Kalapothaki, V.; Hatzakis, A. Human herpesvirus 8 infection in hemodialysis patients. Am. J. Kidney Dis. 2006, 47, 167–170.
42. Whitby, D.; Howard, M.R.; Tenant-Flowers, M.; Brink, N.S.; Copas, A.; Boshoff, C.; Hatzioannou, T.; Suggett, F.E.; Aldam, D.M.; Denton, A.S. et al. Detection of kaposi sarcoma associated herpesvirus in peripheral blood of hiv-infected individuals and progression to kaposi’s sarcoma. Lancet 1995, 346, 799–802.
43. Hladik, W.; Dollard, S.C.; Mermin, J.; Fowlkes, A.L.; Downing, R.; Amin, M.M.; Banage, F.; Nzaro, E.; Kataaha, P.; Dondero, T.J. et al. Transmission of human herpesvirus 8 by blood transfusion. N. Engl. J. Med. 2006, 355, 1331–1338.
44. Hladik, W.; Pellett, P.E.; Hancock, J.; Downing, R.; Gao, H.; Packel, L.; Mimbe, D.; Nzaro, E.; Mermin, J. Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality. J. Infect. Dis. 2012, 206, 1497–1503.
45. Lisco, A.; Barbierato, M.; Fiore, J.R.; Gasperini, P.; Favia, A.; Volpe, A.; Chironna, M.; Pastore, G.; Chieco-Bianchi, L.; Calabro, M.L. Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women. J. Clin. Microbiol. 2006, 44, 3863–3871.
46. Gutierrez-Ortega, P.; Hierro-Orozco, S.; Sanchez-Cisneros, R.; Montano, L.F. Kaposi’s sarcoma in a 6-day-old infant with human immunodeficiency virus. Arch. Dermatol. 1989, 125, 432–433.
47. Ahlfors, K.; Ivarsson, S.A. Cytomegalovirus in breast milk of swedish milk donors. Scand. J. Infect. Dis. 1985, 17, 11–13.
48. Dworsky, M.; Yow, M.; Stagno, S.; Pass, R.F.; Alford, C. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 1983, 72, 295–299.
49. Fujisaki, H.; Tanaka-Taya, K.; Tanabe, H.; Hara, T.; Miyoshi, H.; Okada, S.; Yamanishi, K. Detection of human herpesvirus 7 (hhv-7) DNA in breast milk by polymerase chain reaction and prevalence of hhv-7 antibody in breast-fed and bottle-fed children. J. Med. Virol. 1998, 56, 275–279.
50. Hamprecht, K.; Vochem, M.; Baumeister, A.; Boniek, M.; Speer, C.P.; Jahn, G. Detection of cytomegaloviral DNA in human milk cells and cell free milk whey by nested pcr. J. Virol. Methods 1998, 70, 167–176.
51. Junker, A.K.; Thomas, E.E.; Radcliffe, A.; Forsyth, R.B.; Davidson, A.G.; Rymo, L. Epstein-barr virus shedding in breast milk. Am. J. Med. Sci. 1991, 302, 220–223.
52. Dedicoat, M.; Newton, R.; Alkharsah, K.R.; Sheldon, J.; Szabados, I.; Ndlovu, B.; Page, T.; Casabonne, D.; Gilks, C.F.; Cassol, S.A. et al. Mother-to-child transmission of human herpesvirus-8 in south africa. J. Infect. Dis. 2004, 190, 1068–1075.
53. Brayfield, B.P.; Kankasa, C.; West, J.T.; Muyanga, J.; Bhat, G.; Klaskala, W.; Mitchell, C.D.; Wood, C. Distribution of kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in zambia: Implications for transmission. J. Infect. Dis. 2004, 189, 2260–2270.
54. Boldogh, I.; Szaniszlo, P.; Bresnahan, W.A.; Flaitz, C.M.; Nichols, M.C.; Albrecht, T. Kaposi’s sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin. Infect. Dis. 1996, 23, 406–407.
55. Koelle, D.M.; Huang, M.L.; Chandran, B.; Vieira, J.; Piepkorn, M.; Corey, L. Frequent detection of kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates. J. Infect. Dis. 1997, 176, 94–102.
56. Webster-Cyriaque, J.; Edwards, R.H.; Quinlivan, E.B.; Patton, L.; Wohl, D.; Raab-Traub, N. Epstein-barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions. J. Infect. Dis. 1997, 175, 1324–1332.
57. Casper, C.; Krantz, E.; Selke, S.; Kuntz, S.R.; Wang, J.; Huang, M.L.; Pauk, J.S.; Corey, L.; Wald, A. Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. J. Infect. Dis. 2007, 195, 30–36.
58. Phipps, W.; Saracino, M.; Selke, S.; Huang, M.L.; Jaoko, W.; Mandaliya, K.; Wald, A.; Casper, C.; McClelland, R.S. Oral hhv-8 replication among women in mombasa, kenya. J. Med. Virol. 2014, 86, 1759–1765.
59. DeSantis, S.M.; Pau, C.P.; Archibald, L.K.; Nwanyanwu, O.C.; Kazembe, P.N.; Dobbie, H.; Jarvis, W.R.; Jason, J. Demographic and immune correlates of human herpesvirus 8 seropositivity in malawi, africa. Int. J. Infect. Dis. 2002, 6, 266–271.
60. Plancoulaine, S.; Abel, L.; Tregouet, D.; Duprez, R.; van Beveren, M.; Tortevoye, P.; Froment, A.; Gessain, A. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res. 2004, 64, 8782–8787.
61. Minhas, V.; Crabtree, K.L.; Chao, A.; M’Soka, T.J.; Kankasa, C.; Bulterys, M.; Mitchell, C.D.; Wood, C. Early childhood infection by human herpesvirus 8 in zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area. Am. J. Epidemiol. 2008, 168, 311–320.
62. Alkharsah, K.R.; Dedicoat, M.; Blasczyk, R.; Newton, R.; Schulz, T.F. Influence of hla alleles on shedding of kaposi sarcoma-associated herpesvirus in saliva in an african population. J. Infect. Dis. 2007, 195, 809–816.
63. Olp, L.N.; Shea, D.M.; White, M.K.; Gondwe, C.; Kankasa, C.; Wood, C. Early childhood infection of kaposi’s sarcoma-associated herpesvirus in zambian households: A molecular analysis. Int. J. Cancer 2012, 132, 1182–1190.
64. Wakeham, K.; Webb, E.L.; Sebina, I.; Nalwoga, A.; Muhangi, L.; Miley, W.; Johnston, W.T.; Ndibazza, J.; Whitby, D.; Newton, R. et al. Risk Factors for Seropositivity to Kaposi Sarcoma-Associated Herpesvirus among Children in Uganda. J. Acquir. Immune Defic. Syndr. 2013, 63, 228–233.
65. Butler, L.M.; Were, W.A.; Balinandi, S.; Downing, R.; Dollard, S.; Neilands, T.B.; Gupta, S.; Rutherford, G.W.; Mermin, J. Human Herpesvirus 8 Infection in Children and Adults in a Population-Based Study in Rural Uganda. J. Infect. Dis. 2011, 203, 625–634.
66. Pfeiffer, R.M.; Wheeler, W.A.; Mbisa, G.; Whitby, D.; Goedert, J.J.; de The, G.; Mbulaiteye, S.M. Geographic Heterogeneity of Prevalence of the Human Herpesvirus 8 in Sub-Saharan Africa: Clues about Etiology. Ann. Epidemiol. 2010, 20, 958–963.
67. Coluzzi, M.; Manno, D.; Guzzinati, S.; Tognazzo, S.; Zambon, P.; Arca, B.; Costantini, C.; Ascoli, V. The bloodsucking arthropod bite as possible cofactor in the transmission of human herpesvirus-8 infection and in the expression of kaposi’s sarcoma disease. Parassitologia 2002, 44, 123–129.
68. Lin, C.J.; Katongole-Mbidde, E.; Byekwaso, T.; Orem, J.; Rabkin, C.S.; Mbulaiteye, S.M. Intestinal parasites in kaposi sarcoma patients in uganda: Indication of shared risk factors or etiologic association. Am. J. Trop. Med. Hyg. 2008, 78, 409–412.
69. Whitby, D.; Marshall, V.A.; Bagni, R.K.; Miley, W.J.; McCloud, T.G.; Hines-Boykin, R.; Goedert, J.J.; Conde, B.A.; Nagashima, K.; Mikovits, J. et al. Reactivation of kaposi’s sarcoma-associated herpesvirus by natural products from kaposi’s sarcoma endemic regions. Int. J. Cancer 2007, 120, 321–328.
70. Ziegler, J.L. Endemic kaposi’s sarcoma in africa and local volcanic soils. Lancet 1993, 342, 1348–1351.
71. Renne, R.; Dittmer, D.; Kedes, D.; Schmidt, K.; Desrosiers, R.C.; Luciw, P.A.; Ganem, D. Experimental transmission of kaposi’s sarcoma-associated herpesvirus (kshv/hhv-8) to siv-positive and siv-negative rhesus macaques. J. Med. Primatol. 2004, 33, 1–9.
72. Chang, H.; Wachtman, L.M.; Pearson, C.B.; Lee, J.S.; Lee, H.R.; Lee, S.H.; Vieira, J.; Mansfield, K.G.; Jung, J.U. Non-human primate model of kaposi’s sarcoma-associated herpesvirus infection. PLoS Pathog. 2009, 5, e1000606.
73. Brehm, M.A.; Shultz, L.D.; Greiner, D.L. Humanized mouse models to study human diseases. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17, 120–125.
74. Wege, A.K.; Melkus, M.W.; Denton, P.W.; Estes, J.D.; Garcia, J.V. Functional and phenotypic characterization of the humanized blt mouse model. Curr. Top. Microbiol. Immunol. 2008, 324, 149–165.
75. Wang, L.X.; Kang, G.; Kumar, P.; Lu, W.; Li, Y.; Zhou, Y.; Li, Q.; Wood, C. Humanized-blt mouse model of kaposi’s sarcoma-associated herpesvirus infection. Proc. Natl. Acad. Sci. USA 2014, 111, 3146–3151.
76. Labo, N.; Miley, W.; Marshall, V.; Gillette, W.; Esposito, D.; Bess, M.; Turano, A.; Uldrick, T.; Polizzotto, M.N.; Wyvill, K.M. et al. Heterogeneity and breadth of host antibody response to kshv infection demonstrated by systematic analysis of the kshv proteome. PLoS Pathog. 2014, 10, e1004046.
77. Lennette, E.T.; Blackbourn, D.J.; Levy, J.A. Antibodies to human herpesvirus type 8 in the general population and in kaposi’s sarcoma patients. Lancet 1996, 348, 858–861.
78. Kimball, L.E.; Casper, C.; Koelle, D.M.; Morrow, R.; Corey, L.; Vieira, J. Reduced levels of neutralizing antibodies to kaposi sarcoma-associated herpesvirus in persons with a history of kaposi sarcoma. J. Infect. Dis. 2004, 189, 2016–2022.
79. Inoue, N.; Spira, T.; Lam, L.; Corchero, J.L.; Luo, W. Comparison of serologic responses between kaposi’s sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus. J. Med. Virol. 2004, 74, 202–206.
80. Kumar, P.; Kuwa, N.Y.; Minhas, V.; Marimo, C.; Shea, D.M.; Kankasa, C.; Wood, C. Higher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia. PLoS One 2013, 8, e71254.
81. Lepone, L.; Rappocciolo, G.; Knowlton, E.; Jais, M.; Piazza, P.; Jenkins, F.J.; Rinaldo, C.R. Monofunctional and polyfunctional CD8+ T cell responses to human Herpesvirus 8 lytic and latency proteins. Clin. Vaccine Immunol. 2010, 17, 1507–1516.
82. Robey, R.C.; Mletzko, S.; Gotch, F.M. The T-Cell immune response against kaposi's sarcoma-associated herpesvirus. Adv. Virol. 2010, 2010, 340356.
83. Carrieri, M.P.; Pradier, C.; Piselli, P.; Piche, M.; Rosenthal, E.; Heudier, P.; Durant, J.; Serraino, D. Reduced incidence of kaposi’s sarcoma and of systemic non-hodgkin’s lymphoma in hiv-infected individuals treated with highly active antiretroviral therapy. Int. J. Cancer 2003, 103, 142–144.
84. Franceschi, S.; Maso, L.D.; Rickenbach, M.; Polesel, J.; Hirschel, B.; Cavassini, M.; Bordoni, A.; Elzi, L.; Ess, S.; Jundt, G. et al. Kaposi sarcoma incidence in the swiss hiv cohort study before and after highly active antiretroviral therapy. Br. J. Cancer 2008, 99, 800–804.
85. Ngalamika, O.; Minhas, V.; Wood, C. Kaposi's sarcoma at the university teaching hospital, Lusaka, Zambia in the antiretroviral therapy era. Int. J. Cancer 2014, doi:10.1002/ijc.29184.
86. Bohlius, J.; Valeri, F.; Maskew, M.; Prozesky, H.; Garone, D.; Sengayi, M.; Fox, M.P.; Davies, M.A.; Egger, M. Kaposi’s sarcoma in hiv-infected patients in south africa: Multicohort study in the antiretroviral therapy era. Int. J. Cancer 2014, 135, 2644–2652.
87. Stebbing, J.; Portsmouth, S.; Bower, M. Insights into the molecular biology and sero-epidemiology of kaposi's sarcoma. Curr. Opin. Infect. Dis. 2003, 16, 25–31.